Literature DB >> 22144293

In vivo enhancement in bioavailability of atazanavir in the presence of proton-pump inhibitors using mesoporous materials.

Xin Xia1, Chunfang Zhou, Lluís Ballell, Alfonso E Garcia-Bennett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22144293     DOI： 10.1002/cmdc.201100500

Source DB:  PubMed          Journal:  ChemMedChem        ISSN： 1860-7179            Impact factor:   3.466


× No keyword cloud information.
  5 in total

1.  In silico-assisted development of supersaturable preconcentrated isotropic mixture of atazanavir for augmenting biopharmaceutical performance in the presence of H2-receptor antagonist.

Authors:  Sheshank Sethi; Vikas Rana
Journal:  Drug Deliv Transl Res       Date:  2022-08-03       Impact factor: 5.671

2.  Atazanavir-Concentrate Loaded Soft Gelatin Capsule for Enhanced Concentration in Plasma, Brain, Spleen, and Lymphatics.

Authors:  Sheshank Sethi; Vikas Rana
Journal:  AAPS PharmSciTech       Date:  2022-09-28       Impact factor: 4.026

3.  Encapsulation of Anti-Tuberculosis Drugs within Mesoporous Silica and Intracellular Antibacterial Activities.

Authors:  Xin Xia; Kevin Pethe; Ryangyeo Kim; Lluis Ballell; David Barros; Jonathan Cechetto; HeeKyoung Jeon; Kideok Kim; Alfonso E Garcia-Bennett
Journal:  Nanomaterials (Basel)       Date:  2014-09-11       Impact factor: 5.076

4.  Mechanisms and Extent of Enhanced Passive Permeation by Colloidal Drug Particles.

Authors:  Akshay Narula; Rayan Sabra; Na Li
Journal:  Mol Pharm       Date:  2022-08-23       Impact factor: 5.364

5.  A Novel Approach to Optimize Hot Melt Impregnation in Terms of Amorphization Efficiency.

Authors:  Kamil Garbera; Krzesimir Ciura; Wiesław Sawicki
Journal:  Int J Mol Sci       Date:  2020-06-04       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.